ArticleScientific reports2026
Antibacterial activity, phytochemical profiling and ADMET prediction of bioactive compounds in Origanum syriacum and Salix alba.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ever-increasing global predicament of multidrug-resistant (MDR) infections necessitates the urgent discovery of novel antimicrobials, with medicinal plants representing a promising source of new therapeutic agents. This study investigated the antibacterial efficacy of Origanum syriacum and Salix alba organic and aqueous extracts against the investigated MDR pathogens using plant and bacterial samples sourced from Egypt, with findings expected to inform broader applications beyond this geographic origin. Antibacterial activity of the extracts was evaluated through agar-well diffusion, and MIC was assessed using broth microdilution assay, while the phytochemical composition of potent extracts (acetonic and ethanolic) was characterized using GC-MS analysis. Pharmacokinetic and toxicity profiles of the dominant bioactive compounds were in silico predicted employing ADMET modeling. The results demonstrated that organic extracts exhibited superior and broad-spectrum antibacterial activity compared to aqueous extracts. Notably, O. syriacum acetone extract showed potent effectiveness against MRSA. GC-MS analysis revealed that this efficacy strongly correlates with a high abundance of phenolic monoterpenes, primarily thymol (49.82% in acetone extract). In silico ADMET predictions further identified thymoquinone, eugenol, p-coumaric acid, and ferulic acid as lead compounds, demonstrating favorable drug-likeness, promising oral bioavailability, and manageable toxicological profiles. This integrated approach supports the ethnobotanical use of O. syriacum and S. alba extracts and identifies specific phytochemicals that merit further evaluation as potential therapeutic leads against recalcitrant MDR infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.